Sfoglia per AUTORE
JäNNE PA
Collezione AOU San Luigi di Orbassano

  

Items : 3

HERTHENA-Lung02: phase III study of patritumab deruxtecan in advanced EGFR-mutated NSCLC after a third-generation EGFR TKI. in Future oncology (London, England) / Future Oncol. 2024 May;20(15):969-980. doi: 10.2217/fon-2023-0602. Epub 2023 Dec 14.
2024
AOU San Luigi di Orbassano

Mok T; Jänne PA; Nishio M; Novello S; Reck M; Steuer C; Wu YL; Fougeray R; Fan PD; Meng J; Sternberg DW; Esker S; Yu HA; Mok T; Jänne PA; Nishio M; Novello S; Reck M; Steuer C; Wu YL; Fougeray R; Fan PD; Meng J; Sternberg DW; Esker S; Yu HA;

Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Nov 1;41(31):4852-4863. doi: 10.1200/JCO.23.01361. Epub 2023 Sep 11.
2023
AOU San Luigi di Orbassano

Goto K; Goto Y; Kubo T; Ninomiya K; Kim SW; Planchard D; Ahn MJ; Smit EF; de Langen AJ; Pérol M; Pons-Tostivint E; Novello S; Hayashi H; Shimizu J; Kim DW; Kuo CH; Yang JC; Pereira K; Cheng FC; Taguchi A; Cheng Y; Feng W; Tsuchihashi Z; Jänne PA;

Scientific Advances in Lung Cancer 2015. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2016 May;11(5):613-638. doi: 10.1016/j.jtho.2016.03.012. Epub 2016 Mar 22.
2016
AOU San Luigi di Orbassano

Tsao AS; Scagliotti GV; Bunn PA Jr; Carbone DP; Warren GW; Bai C; de Koning HJ; Yousaf-Khan AU; McWilliams A; Tsao MS; Adusumilli PS; Rami-Porta R; Asamura H; Van Schil PE; Darling GE; Ramalingam SS; Gomez DR; Rosenzweig KE; Zimmermann S; Peters S; Ignatius Ou SH; Reungwetwattana T; Jänne PA; Mok TS; Wakelee HA; Pirker R; Mazières J; Brahmer JR; Zhou Y; et alii...